BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25931286)

  • 1. High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma.
    Udager AM; Rolland DCM; McHugh JB; Betz BL; Murga-Zamalloa C; Carey TE; Marentette LJ; Hermsen MA; DuRoss KE; Lim MS; Elenitoba-Johnson KSJ; Brown NA
    Cancer Res; 2015 Jul; 75(13):2600-2606. PubMed ID: 25931286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinoma.
    Udager AM; McHugh JB; Betz BL; Montone KT; Livolsi VA; Seethala RR; Yakirevich E; Iwenofu OH; Perez-Ordonez B; DuRoss KE; Weigelin HC; Lim MS; Elenitoba-Johnson KS; Brown NA
    J Pathol; 2016 Aug; 239(4):394-8. PubMed ID: 27234382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas.
    Udager AM; McHugh JB; Goudsmit CM; Weigelin HC; Lim MS; Elenitoba-Johnson KSJ; Betz BL; Carey TE; Brown NA
    Ann Oncol; 2018 Feb; 29(2):466-471. PubMed ID: 29145573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic Significance of EGFR Mutation and HPV Infection in Sinonasal Squamous Cell Carcinoma.
    Hongo T; Yamamoto H; Jiromaru R; Nozaki Y; Yasumatsu R; Hashimoto K; Yoneda R; Sugii A; Taguchi K; Masuda M; Nakagawa T; Oda Y
    Am J Surg Pathol; 2021 Jan; 45(1):108-118. PubMed ID: 32868526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR mutation and HPV infection in sinonasal inverted papilloma and squamous cell carcinoma.
    Cabal VN; Menendez M; Vivanco B; Potes-Ares S; Riobello C; Suarez-Fernandez L; Garcia-Marin R; Blanco-Lorenzo V; Lopez F; Alvarez-Marcos C; Llorente JL; Hermsen MA
    Rhinology; 2020 Aug; 58(4):368-376. PubMed ID: 32199023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR and BRAF mutations in inverted sinonasal papilloma - a more complex landscape?
    Zonnur S; Erbersdobler A; Schneider B
    Virchows Arch; 2021 May; 478(5):915-924. PubMed ID: 33048186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sinonasal squamous cell carcinoma and EGFR mutations: a molecular footprint of a benign lesion.
    Sasaki E; Nishikawa D; Hanai N; Hasegawa Y; Yatabe Y
    Histopathology; 2018 Dec; 73(6):953-962. PubMed ID: 30117182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sinonasal papillomas: A single centre experience on 137 cases with emphasis on malignant transformation and EGFR/KRAS status in "carcinoma ex papilloma".
    Maisch S; Mueller SK; Traxdorf M; Weyerer V; Stoehr R; Iro H; Hartmann A; Agaimy A
    Ann Diagn Pathol; 2020 Jun; 46():151504. PubMed ID: 32203683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome sequencing reveals candidate mutations implicated in sinonasal carcinoma and malignant transformation of sinonasal inverted papilloma.
    Viitasalo S; Karhemo PR; Väänänen J; Ilmarinen T; Lilja M; Katainen R; Monni O; Aaltonen LM
    Oral Oncol; 2022 Jan; 124():105663. PubMed ID: 34915258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome and pattern of recurrence of sinonasal squamous cell carcinoma with EGFR-mutation and human papillomavirus.
    Nishikawa D; Sasaki E; Suzuki H; Beppu S; Sawabe M; Terada H; Sone M; Hanai N
    J Craniomaxillofac Surg; 2021 Jun; 49(6):494-500. PubMed ID: 33676817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of p16 expression is a risk factor for recurrence in sinonasal inverted papilloma.
    Menendez M; Cabal VN; Vivanco B; Suarez-Fernandez L; Lopez F; Llorente JL; Hermsen MA; Alvarez-Marcos C
    Rhinology; 2022 Dec; 60(6):453-461. PubMed ID: 36173184
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Pacini L; Cabal VN; Hermsen MA; Huang PH
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of HPV infection, EGFR exon 20 mutations and LINE1 hypomethylation as risk factors for malignant transformation of sinonasal-inverted papilloma to squamous cell carcinoma.
    Sahnane N; Ottini G; Turri-Zanoni M; Furlan D; Battaglia P; Karligkiotis A; Albeni C; Cerutti R; Mura E; Chiaravalli AM; Castelnuovo P; Sessa F; Facco C
    Int J Cancer; 2019 Mar; 144(6):1313-1320. PubMed ID: 30411788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR and KRAS mutations in Chinese patients with sinonasal inverted papilloma and oncocytic papilloma.
    Wang H; Li H; Hu L; Zhou J; Zhai C; Wang D; Sun X
    Histopathology; 2019 Aug; 75(2):274-281. PubMed ID: 30916792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus infection is strictly associated with the metastatic spread of sinonasal squamous-cell carcinomas.
    Doescher J; Piontek G; Wirth M; Bettstetter M; Schlegel J; Haller B; Brockhoff G; Reiter R; Pickhard A
    Oral Oncol; 2015 Oct; 51(10):929-34. PubMed ID: 26272275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptionally Active HPV and Targetable EGFR Mutations in Sinonasal Inverted Papilloma: An Association Between Low-risk HPV, Condylomatous Morphology, and Cancer Risk?
    Mehrad M; Stelow EB; Bishop JA; Wang X; Haynes W; Oliver D; Chernock RD; Lewis JS
    Am J Surg Pathol; 2020 Mar; 44(3):340-346. PubMed ID: 31743131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NGS-based miRNome identifies miR-449 cluster as marker of malignant transformation of sinonasal inverted papilloma.
    Re M; Tomasetti M; Monaco F; Amati M; Rubini C; Foschini MP; Sollini G; Gioacchini FM; Pasquini E; Santarelli L
    Oral Oncol; 2021 Nov; 122():105554. PubMed ID: 34653751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcomes between patients with de-novo sinonasal squamous cell carcinoma vs malignant transformations from inverted papillomas.
    Quan H; Zhang H; Zou L; Yuan W; Wang S
    Int Forum Allergy Rhinol; 2020 Jun; 10(6):762-767. PubMed ID: 32216167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas.
    Brown NA; Plouffe KR; Yilmaz O; Weindorf SC; Betz BL; Carey TE; Seethala RR; McHugh JB; Tomlins SA; Udager AM
    Mod Pathol; 2021 Jun; 34(6):1133-1142. PubMed ID: 33203919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mismatch Repair Deficiency and Somatic Mutations in Human Sinonasal Tumors.
    Hieggelke L; Heydt C; Castiglione R; Rehker J; Merkelbach-Bruse S; Riobello C; Llorente JL; Hermsen MA; Buettner R
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.